Titre-dependent impact of neutralising antibodies to beta-interferon in relapsing-remitting multiple sclerosis

被引：0
|
作者：
O'Rourke, K [1 ]
Hutchinson, M [1 ]
机构：
[1] St Vincents Univ Hosp, Dublin, Ireland
来源：
MULTIPLE SCLEROSIS | 2005年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S160 / S160
页数：1
相关论文
共 50 条
  • [1] In vivo bioactivity of interferon-beta in multiple sclerosis patients with neutralising antibodies is titre-dependent
    Sominanda, A.
    Hillert, J.
    Fogdell-Hahn, A.
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2008, 79 (01): : 57 - 62
  • [2] Predicting beta-interferon failure in relapsing-remitting multiple sclerosis
    O'Rourke, K.
    Walsh, C.
    Antonelli, G.
    Hutchinson, M.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2007, 13 (03) : 336 - 342
  • [3] Clinical importance of neutralising antibodies against interferon beta in patients with relapsing-remitting multiple sclerosis
    Sorensen, PS
    Ross, C
    Clemmesen, KM
    Bendtzen, K
    Frederiksen, JL
    Jensen, K
    Kristensen, O
    Petersen, T
    Rasmussen, S
    Ravnborg, M
    Stenager, E
    Koch-Henriksen, N
    [J]. LANCET, 2003, 362 (9391): : 1184 - 1191
  • [4] Impact of beta-interferon on disability progression in relapsing-remitting multiple sclerosis: a Bayesian analysis
    O'Rourke, K.
    Walsh, C.
    Hutchinson, M.
    [J]. JOURNAL OF NEUROLOGY, 2006, 253 : 102 - 103
  • [5] Pharmacodynamics of interferon-β in relapsing-remitting multiple sclerosis with and without neutralising antibodies
    Scagnolari, G
    Duda, P
    Alberelli, A
    Lavolpe, V
    Bagnato, F
    Girardi, E
    Trojano, M
    Kappos, L
    Antonelli, G
    [J]. MULTIPLE SCLEROSIS, 2004, 10 (7032): : S255 - S255
  • [6] Outcome of beta-interferon treatment in relapsing-remitting multiple sclerosis: a Bayesian analysis
    K. O'Rourke
    C. Walsh
    M. Hutchinson
    [J]. Journal of Neurology, 2007, 254 : 1547 - 1554
  • [7] Outcome of beta-interferon treatment in relapsing-remitting multiple sclerosis: a Bayesian analysis
    O'Rourke, Killian
    Walsh, Cathal
    Hutchinson, Michael
    [J]. JOURNAL OF NEUROLOGY, 2007, 254 (11) : 1547 - 1554
  • [8] Impact of discontinuing interferon beta in patients with relapsing-remitting multiple sclerosis
    Agiela, Mabroka I. M.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2016, 22 (06) : NP5 - NP5
  • [9] Binding and Neutralising Antibodies in Relapsing-remitting Multiple Sclerosis Patients Treated with a Biosimilar Interferon Beta-1a (CinnoVex®)
    Sh, Nafissi
    Shahkarami, M. Amir
    Lam, R.
    Oger, J.
    [J]. MULTIPLE SCLEROSIS, 2010, 16 (02): : 273 - 273
  • [10] The use of interferon beta in relapsing-remitting multiple sclerosis
    Etheridge, LJ
    Beverley, DW
    Ferrie, C
    McManus, E
    [J]. ARCHIVES OF DISEASE IN CHILDHOOD, 2004, 89 (08) : 789 - 791
12345